Collectively, these findings demonstrate forskolin’s capacity to address multiple pathological features of AD, including amyloid plaque accumulation, tau hyperphosphorylation, oxidative stress, neuroinflammation, and synaptic dysfunction. Here, MAPT is linked to Alzheimer disease.